The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Regulatory work for non-profit mental health providers
Represented over a dozen non-profit mental health providers in opposing North Carolina's decision to cut the rate of Medicaid reimbursement by more
Represented group of franchisees who acquired franchise system from their franchisor in settlement of litigation
Represented group of franchisees who acquired franchise system from their franchisor in settlement of litigation and converted the system into a more
Patent litigation for global supplier of IT solutions for banks
The firm served as lead counsel on behalf of a global supplier of IT solutions for banks. Disc Link Corp. (“Disc Link”), a subsidiary of the patent more
Mr. Electric Corp. v. Reiad Khalil, et. al.
Achieved a win on behalf of our client, The Dwyer Group, and specifically its Mr. Electric subsidiary, against Alber Electric, a business operated by more